Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens.

Publication Type:

Journal Article


The Journal of infectious diseases, Volume 201, Issue 1, p.132-41 (2010)


2010, Adenoviridae, Adjuvants, Immunologic, Adult, AIDS Vaccines, Center-Authored Paper, DNA, Viral, Female, Genes, gag, HIV-1, Humans, Immunization, Secondary, Male, Middle Aged, Placebos, Vaccine and Infectious Disease Division, Young Adult


We report composite results from the Merck phase I program of near-consensus clade B human immunodeficiency virus (HIV) type 1 gag vaccines.